Search Criteria
Scheme Search
Microbiology
Specimens
3 simulated swab/urine samples, 2 mL.
Examinations
Detection of C. trachomatis and N. gonorrhoeae nucleic acid.
Important Notes
See also scheme 5302 Sexually transmitted diseases multiplex, nucleic acid detection. The samples contain hDNA.
Microbiology
Specimens
2 lyophilised mixtures of bacteria.
Examinations
This scheme includes C. difficile culture, antigen detection (GDH), toxin detection and direct nucleic acid detection. Hypervirulent C. difficile strains also included.
Important Notes
Microbiology
Specimens
2 lyophilised mixtures of bacteria
Examinations
C. difficile direct nucleic acid detection. Hypervirulent C. difficile strains also included
Important Notes
5200 includes also this examination. Four rounds per year.
Microbiology
Specimens
5 samples simulating plasma, 1.5 mL
Examinations
CMV and EBV NAT (quantitative).
Important Notes
Quantitative result processing.
Microbiology
Specimens
3 human serum or plasma samples, 0.5 mL. Authentic, commutable samples from a single human donor or occasionally simulated samples.
Examinations
Dengue virus IgG and IgM antibodies, Dengue virus antigen (NS1) and post-analytical clinical interpretation.
Important Notes
For clinical laboratories and POCT sites.
Multiplex
Specimens
3 samples. Either lyophilised mixtures of bacteria and/or simulated samples, 1 mL.
Examinations
Direct nucleic acid detection. Pathogens included are Aeromonas, Campylobacter, E. coli EHEC (stx1/stx2), E. coli EAEC, E. coli EIEC, E. coli EPEC, E. coli ETEC, Plesiomonas, Salmonella, Shigella and Yersinia.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered.
Multiplex
Specimens
3 lyophilised samples.
Examinations
Nucleic acid detection of Cryptosporidium, Dientamoeba fragilis, Entamoeba histolytica and Giardia lamblia.
Important Notes
Microbiology
Specimens
3 samples: lyophilised faecal.
Examinations
Antigen detection.
Important Notes
For clinical laboratories and POCT sites.
Microbiology
Specimens
3 lyophilsed or liquid plasma samples, 1.2 mL
Examinations
HBV DNA, quantitative and/or qualitative nucleic acid detection
Important Notes
Microbiology
Specimens
3 lyophilised or liquid plasma samples, 1.2 mL
Examinations
HCV RNA, quantitative and/or qualitative nucleic acid detection
Important Notes
Microbiology
Specimens
3 liquid human plasma samples, 0.7 mL
Examinations
HIVAb (1/2), HIVAgAb (combo), HIVAg (p24), HIVAb confirmatory test and post-analytical clinical interpretation. Positive specimens may include HIV-1 or HIV-2
Important Notes
Comprehensive HIV screening and confirmatory testing for clinical laboratories. Four rounds per year.
Microbiology
Specimens
3 liquid human plasma samples, 0.5 mL
Examinations
HIVAb and HIVAgAb (combo) POCT
Important Notes
This scheme is only for POC tests. Scheme 5091 is for clinical laboratories. Four rounds per year.